PCSK9 Inhibitor
6 drugs across 2 manufacturers|0 Generic,6 Brand
The PCSK9 Inhibitor class contains 6 NDCs from 2 manufacturers (0 generic, 6 brand), at an average NADAC of $273.88 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
6
0G / 6B
Manufacturers
2
Avg $273.8788/unit
Avg 7d Change
-0.01%
Across 1 drugs with changes
7d Activity
of 6 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REPATHA 140 MG/ML SURECLICK Evolocumab | $281.9611 per ML | 0.00% |
REPATHA 140 MG/ML SURECLICK Evolocumab | $281.9611 per ML | 0.00% |
REPATHA 140 MG/ML SYRINGE Evolocumab | $281.8058 per ML | — |
REPATHA 140 MG/ML SYRINGE Evolocumab | $281.8058 per ML | — |
PRALUENT 150 MG/ML PEN alirocumab | $258.0073 per ML | -0.01% |
PRALUENT 75 MG/ML PEN alirocumab | $257.7316 per ML | 0.00% |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Amgen Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Evolocumab market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the PCSK9 Inhibitor class?
The PCSK9 Inhibitor class contains 6 NDCs from 2 manufacturers — 0 generic and 6 brand products.
What is the average price of PCSK9 Inhibitor drugs?
The average NADAC for the PCSK9 Inhibitor class is $273.8788 per unit across 6 NDCs.
Which manufacturers make PCSK9 Inhibitor drugs?
2 manufacturers make drugs in the PCSK9 Inhibitor class. Ranked by number of NDCs, the largest are Amgen Inc. (4), Regeneron Pharmaceuticals, Inc. (2).
How has PCSK9 Inhibitor pricing changed recently?
Over the past 7 days, 0 NDCs in this class rose and 1 fell, with a class-wide average change of -0.0%.